BioPharma Dive - Latest News

Praxis hits trial setback; Bristol Myers lays off staff in New Jersey

The brain drug developer is continuing a trial despite a recommendation it be stopped for futility. Elsewhere, Eli Lilly struck a molecular glue deal and Zevra sold a priority review voucher.

Feb 28, 2025 - 17:59
 0
Praxis hits trial setback; Bristol Myers lays off staff in New Jersey

The brain drug developer is continuing a trial despite a recommendation it be stopped for futility. Elsewhere, Eli Lilly struck a molecular glue deal and Zevra sold a priority review voucher.

Read More

Tags:

Previous Article

Eli Lilly feels Magnet's pull with molecular glue deal potentially worth $1.25B

Next Article

New Products: Protein Options Abound, Talking Rain Enters Prebiotic Soda

Related Posts

Pfizer stops selling hemophilia gene therapy, citing weak demand

Pfizer stops selling hemophilia gene therapy, citing we...

Feb 21, 2025  0

Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions

Tariffs raise concern among generic drugmakers, as advo...

Feb 10, 2025  0

Sanofi, Teva add to case for new bowel disease drug

Sanofi, Teva add to case for new bowel disease drug

Feb 24, 2025  0